We aimed to develop a new approach to risk stratification using metabolic syndrome as well as traditional non-metabolic risk factors, and to examine its validity in carotid atherosclerosis. Methods: A total of 1,189 men and women aged 21-93 years old were stratified according to the absence or presence of metabolic syndrome defined by Japanese criteria, non-metabolic risk factors, and a past history of coronary heart disease. The risk stratification was as follows: (S-1) persons without a past history, non-metabolic risk factors and metabolic syndrome, (S-2a) those with metabolic syndrome only, (S-2b) those with non-metabolic risk factors only, (S-3) those with non-metabolic risk factors and metabolic syndrome but no past history, and (S-4) those with a past history. Carotid atherosclerosis was defined as maximum intima-media thickness ≥1.1 mm of the far wall of the common carotid artery. Results: Compared with individuals without these three risk components (S-1), the odds ratio was 7.2 (2.8-18.6) for a past history (S-4), 4.3 (1.7-10.9) for non-metabolic risk factors plus metabolic syndrome but no past history (S-3), 2.6 (1.1-6.4) for non-metabolic risk factors only (S-2b) and 0.5 (0.0-5.7) for metabolic syndrome only (S-2a). Net reclassification improvement from metabolic syndrome only (presence versus absence) to our risk stratification ( ≥ S-3 versus S-3) was 16.4% (p 0.0001), suggesting that our risk stratification improved the classification of atherosclerosis in comparison to metabolic syndrome only. Conclusion: Risk stratification based on traditional non-metabolic risk factors plus metabolic syndrome rather than metabolic syndrome only appears to be more useful for the clinical assessment of atherosclerosis, and probably in the prevention and control of atherosclerotic disease. J Atheroscler Thromb, 2011; 18:504-512.
with and without metabolic syndrome to reduce misclassified high-risk patients in general clinical practice.
The Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel ), Final Report 3) concludes that individuals with a past history of cardiovascular disease have a substantially higher risk of coronary heart disease than those without, and that current smoking, older age, and a family history of cardiovascular disease are independent risk factors for coronary heart disease. Because these risk factors are easy to identify in general clinical practice, reclassification using this information as well as metabolic syndrome may be more useful for the clinical assessment of atherosclerosis.
For identification in clinical practice of groups at high risk of atherosclerotic disease, we attempted to develop a new method of risk stratification based on the combination of metabolic syndrome and traditional non-metabolic risk factors. We also examined the validity of this new stratification method in terms of intima-media thickness (IMT) of carotid arteries.
Materials and Methods

Study Population
We, the Defining Vascular Disease (DVD) group, conducted a cross-sectional study of 41 collaborating clinical centers in 2004. Healthy individuals and patients with cardiovascular disease, who had clinical records of risk factors and a history of cardiovascular disease, were recruited as study subjects from the institutes. They consisted of 3,415 individuals (2,034 men and 1,381 women) aged 16 to 97 years. We recruited the participants at health check-ups and from clinical outpatients at each clinical institute. The average number of participants was 88 with 631 maximum, and the percentage of individuals with a past history of coronary heart disease was 0% to 17% among the 41 institutes. Informed consent was obtained to conduct an epidemiological study based on guidelines of the Council for International Organizations of Medical Science 18) . The study protocol was approved by each institute's human ethics review committee.
We excluded 1,422 individuals who did not undergo carotid ultrasound examination and 804 without data of a past and/or family history and/or waist circumference. We did not exclude patients with familial hypercholesterolemia, because we did not collect that information; however, none of the subjects had serum total cholesterol levels ≥ 500 mg/dL. Therefore, 1,189 individuals (581 men and 608 women), 21 to 93 years old, from 18 clinical centers were enrolled in this study.
Cardiovascular Risk Factors
The cardiovascular risk factor data included age, height and weight, waist, circumference systolic and diastolic blood pressure, serum total cholesterol, HDL-cholesterol, triglycerides and glucose at fasting, hs-CRP, use of medication for hypertension, hyperlipidemia and diabetes mellitus, smoking status (never smoker, ex-smoker, and current smoker), alcohol intake category (never drinker, ex-drinker, and current drinker), past history of coronary heart disease, past history of other vascular diseases (transient ischemic attack, stroke, arteriosclerosis thrombangiitis obliterans, and/or aortic aneurysm), and a family history of coronary heart disease. We calculated body mass index (BMI) as weight (kg) divided by the square of height in meters (m 2 ), LDL-cholesterol with the Friedewald formula 19) as LDL-cholesterol (mg/dL) total cholesterol (mg/dL) HDL-cholesterol (mg/dL) 0.2 triglycerides (mg/dL), and the LDL/HDL ratio as LDLcholesterol (mg/dL)/HDL-cholesterol (mg/dL). Only two individuals had severely high levels of triglycerides ( ≥ 800 mg/dL), and we treated then as missing LDLcholesterol, because the estimated LDL-cholesterol may have been biased.
Identification of Carotid Atherosclerosis
Carotid arteries were evaluated with high-resolution B-mode ultrasonography. We adopted the same ultrasonography protocol used in one of the largest population-based studies of carotid atherosclerosis conducted among elderly Americans, i.e., the Cardiovascular Health Study 20) . The imaging protocol involved obtaining a single longitudinal lateral view of the distal 10 mm of the right and left common carotid arteries (CCAs). To quantify the degree of thickening of the carotid artery walls, we assessed the maximum IMT of CCA, which was defined as the thickest section of either the far right or left wall of the CCA. Carotid atherosclerosis was measured at each clinical center. The carotid atherosclerosis measurement was not standardized, but we assumed that the maximum IMT of CCA is frequently measured in clinical practice and may be reliable. Carotid atherosclerosis was defined as maximum IMT of CCA ≥ 1.1 mm.
Risk Stratification Algorithm
For risk stratification, we used the presence or absence of 1) a past history of coronary heart disease, 2) non-metabolic risk factors and 3) metabolic syndrome, data which are easily obtained in medical prac-tice.
The definition by the Japanese Committee to Evaluate Diagnostic Standards for Metabolic Syndrome 6, 7) was used for the diagnosis of metabolic syndrome. This definition is based on abdominal obesity (waist ≥ 85 cm for men and ≥ 90 cm for women) plus two or more components of metabolic risk factors, namely, 1) high blood pressure: ≥ 130/85 mmHg; 2) high glucose: fasting glucose ≥ 6.1 mmol/L (110 mg/dL); 3) dyslipidemia: HDL cholesterol 1.03 mmol/L (40 mg/dL) and/or triglycerides ≥ 1.69 mmol/L (150 mg/dL).
We stratified the participants into five categories (S-1, S-2a, S-2b, S-3, and S-4) based on the absence or presence of 1) a past history of coronary heart disease, 2) non-metabolic risk factors, and 3) metabolic syndrome (Fig. 1) . Non-metabolic risk factors were: 2-1) older age: ≥ 45 years for men and ≥ 55 years for women, 2-2) current smoker, 2-3) family history of coronary heart disease, and 2-4) past history of other vascular diseases (transitory ischemic attack, stroke, arteriosclerosis obliterans, and/or aortic aneurysm). Although LDL-cholesterol levels or novel risk factors such as hs-CRP were not used for our risk stratification, they were used as adjustment variables.
Statistical Analysis
Student's t test and the chi square test were used to compare the characteristics of subjects with and without carotid atherosclerosis. A logistic regression model including the random effect of clinical-center levels was used to calculate crude and multivariable odds ratios (ORs) and 95% confidence intervals (95%CIs) for carotid atherosclerosis according to risk stratification. Tertiles of hs-CRP and the LDL/HDL ratio were used for multivariable adjustment as potential confounding factors, because the distribution of hs-CRP and the LDL/HDL ratio were skewed.
To assess the improvement of misclassification using our risk stratification, we calculated net reclassification improvement 21) , which focuses on reclassification tables constructed separately for participants with and without incidences and quantifies the correct movement in categories.
All statistical tests were two-sided and p 0.05 was regarded as significant. SAS, version 9.13 (SAS Institute, Inc., Cary, NC, USA) was used for all statistical analyses.
Results
Risk Factors between Subjects with and without Carotid Atherosclerosis
Compared with subjects without carotid atherosclerosis, those with carotid atherosclerosis were older, more likely to smoke, to use medication for hypertension and hyperlipidemia, and to have a past history of coronary heart disease and other vascular diseases, and were less likely to drink ( Table 1) . They also had higher mean values of weight, body mass index, waist Non-metabolic risk factors include older age, current smoking, family history of coronary heart disease, and a past history of other vascular diseases.
circumference, systolic and diastolic blood pressure, fasting blood glucose, LDL/HDL ratio, and triglycerides, and lower mean values of HDL-cholesterol, and to have metabolic syndrome. These results did not change substantially after stratification for men and women; therefore, further analyses were conducted for men and women combined, adjusted for sex.
Odds Ratios of carotid Atherosclerosis According to Risk Factors
A significantly higher prevalence of carotid atherosclerosis was observed in association with each of the components except current smoking, a past history of other vascular diseases and a family history of coronary heart disease ( Table 2 ). The multivariable odds ratios (95% confidence intervals) for carotid atherosclerosis were 2.5 (1.6-3.9; p 0.0004) for the presence versus absence of a past history, 3.8 (1.7-8.8; p 0.003) for the presence versus absence of non-metabolic risk factors, and 1.4 (1.0-2.0; p 0.04) for the presence versus absence of metabolic syndrome. These results were similar for men and women (not shown in the table). Among the components of metabolic syndrome, high blood pressure and then high glucose were strongly associated with the prevalence of carotid atherosclerosis.
Risk Stratification Algorism and Odds Ratio of Carotid Atherosclerosis
After risk stratification (Table 3 and Fig. 2) , we observed the higher prevalence of carotid atherosclerosis in high-risk categories (S-2b, S-3, and S-4), compared with the reference category (S-1). Adjustment for potential confounding factors, i.e., sex, drinking status, hs-CRP, and the LDL/HDL ratio, did not result in a substantial change in these associations. The multivariable odds ratios (95%CI) for the study population compared to subjects without a past history, non-metabolic risk factors and metabolic syndrome (S-1) were 7.2 (2.8-18.6) for subjects with a past history (S-4), 4.3 (1.7-10.9) for those with non-metabolic risk factors and metabolic syndrome but no past history (S-3), 2.6 (1.1-6.4) for those with non-metabolic risk factors but no metabolic syndrome and no past history (S-2b), and 0.5 (0.0-5.7) for those with metabolic syndrome but no other two risk components (S-2a). Net reclassification improvement from metabolic syndrome only (presence versus absence) to our risk stratification ( ≥ S-3 versus S-3) was 16.4% (p 0.0001), suggesting that our risk stratification improved the classification of atherosclerosis in comparison to metabolic syndrome only. The odds ratios of potential confounding factors was 1.2 (0.8-1.6) for sex (men versus women), 0.8 (0.6-1.1) for drinking status (current versus never drinkers), 1.2 (0.8-1.6) for hs-CRP (the highest versus lowest categories), and 1.9 (1.3-2.8) for LDL/HDL ratio (the highest versus lowest categories).
When subjects in S-1 were further divided into those without any metabolic risk factors (S-1a) and those with metabolic risk factors (S-1b), these was only one case of carotid atherosclerosis in S-1a and seven in S-1b (not shown in Table) . The respective multivariable odds ratio of carotid atherosclerosis with reference to S-1a was 2.8 (0.3-30.3) for S-1b, 1.1 (0.1-25.6) for S-2a, 5.8 (0.7-51.6) for S-2b, 9.5 (1.1-85.8) for S-3, and 15.9 (1.7-146.5) for S-4.
Odds Ratio According to Risk Factors Stratified by Abdominal Obesity
Of 996 subjects with metabolic risk factors, 552 (55%) had no abdominal obesity but had a similarly high prevalence of a past history for coronary heart disease (17.9% versus 19.1%) and of non-metabolic risk factors (93.1% versus 96.6%), as did those with abdominal obesity (not shown in Table) . As shown in Table 4 , we observed a higher prevalence of carotid atherosclerosis in subjects with the higher number of metabolic risk factors, irrespective of abdominal obesity. Subjects with abdominal obesity but no other metabolic risk factors had higher age-and sex-adjusted triglyceride levels (67.1 mg/dL versus 89.6 mg/dL; p 0.001) and lower HDL-cholesterol levels (64.8 mg/dL versus 57.7 mg/dL; p 0.009) than those without abdominal obesity or other metabolic risk factors (not shown in Table) . There were no differences in the mean blood pressure, glucose and LDL-cholesterol levels between them. The excess prevalence of carotid atherosclerosis was similarly observed for subjects with each metabolic risk factor, i.e. high blood pressure, high glucose and dyslipidemia, irrespective of abdominal obesity ( Table 4) .
Discussion
In this large cross-sectional study of Japanese men and women, we developed a new risk stratification for prevention and control of atherosclerotic dis- ease based on non-metabolic risk factors (past history of coronary heart disease, older age, current smoker, family history of coronary heart disease, past history of other vascular diseases) and metabolic syndrome, which we can easily obtain in general clinical practice. We also examined the validity of this risk stratification in relation to intima-media thickness (IMT) of common carotid arteries as an indicator of carotid atherosclerosis. Our risk stratification may improve the detection of carotid atherosclerosis, compared with that using metabolic syndrome alone, since the net reclassification improvement from metabolic syndrome only to our risk stratification was large (16.4%, p 0.0001).
The advantage of our risk stratification is its ease of application because we used general information from medical interviews and metabolic risk factors. Previous frames for risk stratifications required the measurement of serum total cholesterol 22, 23) , creatinine, aspartate transaminase, alanine transaminase and urinary protein 22) , total cholesterol 23) and LDL-cholesterol 24) , but some risk factors (e.g. total cholesterol) and creatinine are no longer measured in the Japanese nationwide screening and intervention program for metabolic syndrome 16) . Subjects with both non-metabolic risk factors plus metabolic syndrome (S-3) had a 4.3 times higher risk of atherosclerotic disease than the reference group (S-1), while the risk for subjects with non-metabolic risk factors only (S-2b) was still 2.6 times higher. This result suggests the importance of non-metabolic risk factors in the risk stratification of high-risk individuals, as described in a previous study 24) . On the other hand, the presence of metabolic syndrome was associated with a higher risk of atherosclerotic disease among subjects with non-metabolic risk factors. Subjects with non-metabolic risk factors plus metabolic syndrome (S-3) had a 1.7 higher prevalence of carotid atherosclerosis than those with nonmetabolic risk factors only (S-2b); therefore, our results suggest the importance of both metabolic syndrome and non-metabolic risk factors for the detection of atherosclerotic disease.
It also should be mentioned that subjects without metabolic syndrome included high-risk individuals, such as those with high blood pressure, high glucose, or dyslipidemia but not abdominal obesity, when we used the Japanese criteria for metabolic syndrome Table 3 . Crude and multivariable odds ratio (95% confidence interval) for subjects with ≥ 1.1 mm of IMT(intima-media thickness)-Cmax-far wall according to risk stratification using a past history of coronary heart disease, non-metabolic risk factors and metabolic syndrome for men and women combined.
Past history of coronary heart disease
Names of categories : Adjusted for sex, drinking status, hs-CRP (tertile), and LDL/HDL ratio (tertile).
Fig. 2. Multivariable odds ratio (95% confidence interval) for
subjects with ≥ 1.1 mm IMT (intima-media thickness) according to risk stratification using a past history of coronary heart disease, non-metabolic risk factors and metabolic syndrome. where abdominal obesity as an essential component. In fact, 55% of subjects with metabolic risk factors had no abdominal obesity but had a similar high prevalence of a past history of coronary heart disease and non-metabolic risk factors, as did those with abdominal obesity. Subjects with and without abdominal obesity also had a similar high prevalence of carotid atherosclerosis. Our finding correlates with the results from recent cohort studies that non-overweight individuals with metabolic risk factors had a similar excess risk of cardiovascular disease to overweight individuals with metabolic risk factors 14, 15, 17) . There are a few limitations to our study. First, the epidemiological data were obtained from a crosssectional study. A causal inference could thus not be assessed. However, evidence from previous cohort studies and clinical trials supports the causality of metabolic syndrome and non-metabolic risk factors in the development of atherosclerosis. Second, our study participants were recruited from medical centers, which may have caused a selection bias. In fact, the prevalence of metabolic syndrome (28.1% for men and 25.7% for women) was higher than in the national survey (23.0% for men and 8.9% for women), especially for women 25) . Risk prediction in our study may thus have been underestimated. Third, carotid atherosclerosis was measured at each clinical center, and was not centralized; however, previous studies showed that the assessment of maximum IMT of CCA ≥ 1.1 mm had high reliability and was of use for the prediction of coronary heart disease events 20, 26, 27) . Fourth, we did not measure some potential cardiovascular risk factors (e.g. socioeconomic status and psychosocial factors), which may have led to residual confounding. Fifth, in our primary analysis, we did not divide S-1 into those without any metabolic risk factors (S-1a) and those with metabolic risk factors (S-1b) due to the relatively small sample size of cases in S-1; however, as discussed above, subjects with high blood pressure, high glucose or dyslipidemia, but not abdominal obesity were also likely to be at high risk. Thus, we need to pay attention to these patients in the prevention and control of atherosclerotic disease. Finally, we recruited participants with a wide range of health status (i.e. health check-ups and clinical outpatients), and excluded 2,226 subjects from our analyses due to missing data. These selections may have led to potential bias; therefore, further studies are necessary to confirm the generalizability of our risk stratification.
In summary, the study presented here provides epidemiological evidence that risk stratification based on metabolic syndrome as well as non-metabolic risk Table 4 . Multivariable odds ratios (OR) and 95% confidence intervals (95%CI) of carotid atherosclerosis according to metabolic risk factors stratified by abdominal obesity for men and women combined factors is useful for the clinical assessment of atherosclerosis and probably in the prevention and control of atherosclerotic disease. We also need to pay attention to high-risk individuals without abdominal obesity, but with high blood pressure, high glucose or dyslipidemia.
